Clinical Trial

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 2

Study Status:

Active

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is to evaluate the safety and efficacy of mirikizumab in maintaining remission at Week 40 in patients who completed the 12-week iduction study 16T-MC-AMAN.

Information:

Principal Investigator	Sriramachandra Badiga, MD
Type of Trial	Prospective/Interventional

Contact Us For More Info Or To Apply

5323 S. McColl Rd., Edinburg, TX 78539

[email protected]

(956) 362-2390

Clinical Trial

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 2

Study Status:

Study Purpose:

Information:

Useful Links

For Research Participants

About Us

News & Views